Thompson TC - Search Results

1

Caveolin and lipid domains-close companions in managing cellular pathways.

Vykoukal JV, Fahrmann JF, Thompson TC. Vykoukal JV, et al. Among authors: thompson tc. Cancer Metastasis Rev. 2020 Jun;39(2):341-342. doi: 10.1007/s10555-020-09891-w. Cancer Metastasis Rev. 2020. PMID: 32417992 No abstract available.

2

Metastasis-related genes in prostate cancer: the role of caveolin-1.

Thompson TC. Thompson TC. Cancer Metastasis Rev. 1998-1999;17(4):439-42. doi: 10.1023/a:1006110326366. Cancer Metastasis Rev. 1998. PMID: 10453288 Review.

3

Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker.

Yang G, Truong LD, Wheeler TM, Thompson TC. Yang G, et al. Among authors: thompson tc. Cancer Res. 1999 Nov 15;59(22):5719-23. Cancer Res. 1999. PMID: 10582690

4

Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.

Satoh T, Yang G, Egawa S, Addai J, Frolov A, Kuwao S, Timme TL, Baba S, Thompson TC. Satoh T, et al. Among authors: thompson tc. Cancer. 2003 Mar 1;97(5):1225-33. doi: 10.1002/cncr.11198. Cancer. 2003. PMID: 12599229 Free article.

5

Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.

Yang G, Timme TL, Frolov A, Wheeler TM, Thompson TC. Yang G, et al. Among authors: thompson tc. Cancer. 2005 Mar 15;103(6):1186-94. doi: 10.1002/cncr.20905. Cancer. 2005. PMID: 15712208 Free article.

6

Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.

Tahir SA, Yang G, Goltsov AA, Watanabe M, Tabata K, Addai J, Fattah el MA, Kadmon D, Thompson TC. Tahir SA, et al. Among authors: thompson tc. Cancer Res. 2008 Feb 1;68(3):731-9. doi: 10.1158/0008-5472.CAN-07-2668. Cancer Res. 2008. PMID: 18245473

7

The role of caveolin-1 in prostate cancer: clinical implications.

Thompson TC, Tahir SA, Li L, Watanabe M, Naruishi K, Yang G, Kadmon D, Logothetis CJ, Troncoso P, Ren C, Goltsov A, Park S. Thompson TC, et al. Prostate Cancer Prostatic Dis. 2010 Mar;13(1):6-11. doi: 10.1038/pcan.2009.29. Epub 2009 Jul 7. Prostate Cancer Prostatic Dis. 2010. PMID: 19581923 Free PMC article. Review.

8

Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models.

Tahir SA, Kurosaka S, Tanimoto R, Goltsov AA, Park S, Thompson TC. Tahir SA, et al. Among authors: thompson tc. Cancer Biol Ther. 2013 Feb;14(2):117-26. doi: 10.4161/cbt.22633. Epub 2012 Oct 31. Cancer Biol Ther. 2013. PMID: 23114714 Free PMC article.

9

Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer.

Tahir SA, Yang G, Goltsov A, Song KD, Ren C, Wang J, Chang W, Thompson TC. Tahir SA, et al. Among authors: thompson tc. Cancer Res. 2013 Mar 15;73(6):1900-11. doi: 10.1158/0008-5472.CAN-12-3040. Epub 2013 Jan 9. Cancer Res. 2013. PMID: 23302227 Free PMC article.

10

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer.

Vykoukal J, Fahrmann JF, Gregg JR, Tang Z, Basourakos S, Irajizad E, Park S, Yang G, Creighton CJ, Fleury A, Mayo J, Paulucci-Holthauzen A, Dennison JB, Murage E, Peterson CB, Davis JW, Kim J, Hanash S, Thompson TC. Vykoukal J, et al. Among authors: thompson tc. Nat Commun. 2020 Aug 27;11(1):4279. doi: 10.1038/s41467-020-17645-z. Nat Commun. 2020. PMID: 32855410 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

260 results

Search Page